Late-Stage Use of Low-Dose Corticosteroids Aid Recovery of Severe H1N1 Viral Pneumonia

Infection International
doi 10.1515/ii-2017-0054
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Walter de Gruyter GmbH

Related search

Con: Corticosteroids Are Not Indicated for Treatment of Acute Lung Injury From H1N1 Viral Pneumonia

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2011English

Low-Dose Corticosteroid Use and Mortality in Severe Community-Acquired Pneumonia Patients

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2014English

Potential Benefits of Precise Corticosteroids Therapy for Severe 2019-nCoV Pneumonia

Signal Transduction and Targeted Therapy
Cancer ResearchGenetics
2020English

The Role of Corticosteroids in Severe Community-Acquired Pneumonia: A Systematic Review

Critical Care
Critical CareIntensive Care Medicine
2008English

The Role of Corticosteroids in Severe Community-Acquired Pneumonia: A Systematic Review

Critical Care
Critical CareIntensive Care Medicine
2008English

Severe Cases of Pandemic H1N1 Pneumonia and Respiratory Failure Requiring Intensive Care

Journal of Intensive Care Medicine
Critical CareIntensive Care Medicine
2011English

Severe Bleomycin Lung Toxicity: Reversal With High Dose Corticosteroids.

Thorax
PulmonaryRespiratory Medicine
1993English

Successful Management of Severe Acute Respiratory Distress Syndrome Caused by H1N1 Viral Pneumonia Using Early Institution of Extra Corporeal Membrane Oxygenation Therapy

International Journal of Research in Medical Sciences
2018English

Genetic Variants Associated With Severe Pneumonia in a/H1n1 Influenza Infection

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy